Interferon‐β1a therapy in human T‐lymphotropic virus type I–associated neurologic disease

Human T‐lymphotropic virus type I (HTLV‐I)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune‐mediated inflammatory disorder of the central nervous system. Immune activation in the host, which results from high levels of persistent antigenic stimulation and from transactivation of host immunoregulatory genes by HTLV‐I, appears important in the pathogenesis of HAM/TSP. In a single‐center, open‐label trial, 12 patients with HAM/TSP were treated with doses of interferon‐β1a of up to 60μg twice weekly, based on its antiviral and immunomodulatory effects. Primary end points were immunological and virological measures that are potential biomarkers for HAM/TSP. Interferon‐β1a therapy reduced the HTLV‐I tax messenger RNA load and the frequency of potentially pathogenic HTLV‐I–specific CD8+ cells. The HTLV‐I proviral DNA load remained unchanged. Spontaneous lymphoproliferation, a marker of T‐cell activation in HAM/TSP, also was reduced. Some measures of motor function were improved, and no significant clinical progression occurred during therapy. These results indicate that interferon‐β1a may beneficially affect the immune mechanisms central to the pathogenesis of HAM/TSP. Ann Neurol 2005;57:526–534

[1]  S. Jacobson,et al.  Increased Expression of Human T Lymphocyte Virus Type I (HTLV-I) Tax11-19 Peptide–Human Histocompatibility Leukocyte Antigen A*201 Complexes on CD4+ CD25+T Cells Detected by Peptide-specific, Major Histocompatibility Complex–restricted Antibodies in Patients with HTLV-I–associated Neurologic Disease , 2004, The Journal of experimental medicine.

[2]  D. Smith,et al.  Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study , 2003, Neurology.

[3]  D. Maric,et al.  Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide–HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections , 2003, Nature Medicine.

[4]  S. Jacobson.  Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. , 2002, The Journal of infectious diseases.

[5]  T. Waldmann,et al.  IFN Regulatory Factor 4 Participates in the Human T Cell Lymphotropic Virus Type I-Mediated Activation of the IL-15 Receptor α Promoter1 , 2002, The Journal of Immunology.

[6]  Masahiro Nagai,et al.  Increased HTLV‐I proviral load and preferential expansion of HTLV‐I tax‐specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP , 2001, Annals of neurology.

[7]  T. Waldmann,et al.  Human T Cell Lymphotropic Virus Type I Tax Activates IL-15Rα Gene Expression Through an NF-κB Site , 2001, The Journal of Immunology.

[8]  T. Greten,et al.  Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. , 2001, The Journal of infectious diseases.

[9]  P. Roberts,et al.  Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.

[10]  R. Martin,et al.  An Altered Peptide Ligand Antagonizes Antigen-Specific T Cells of Patients with Human T Lymphotropic Virus Type I-Associated Neurological Disease , 2000, The Journal of Immunology.

[11]  S. Jacobson,et al.  HTLV-I specific IFN-γ+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals , 2000, Journal of Neuroimmunology.

[12]  T. Waldmann,et al.  Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. , 1999, Journal of immunology.

[13]  S. Izumo,et al.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.

[14]  J. D. White,et al.  Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac , 1998, Annals of neurology.

[15]  T. Waldmann,et al.  Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site , 1998 .

[16]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[17]  D. Taub,et al.  Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. , 1997, Journal of immunology.

[18]  Y. Itoyama,et al.  Interferon-alpha is effective in HTLV-I-associated myelopathy , 1996, Neurology.

[19]  C. Granger,et al.  Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.

[20]  C. Fox,et al.  Detection of human T‐lymphotropic virus type I (HTLV‐I) tax RNA in the central nervous system of HTLV‐I–associated myelopathy/tropical spastic paraparesis patients by in situ hybridization , 1995, Annals of neurology.

[21]  H. Ikeda,et al.  Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. , 1994, The Journal of clinical investigation.

[22]  T. Lehky,et al.  Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells , 1994, Journal of virology.

[23]  I. Elovaara,et al.  High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease , 1993, The Journal of experimental medicine.

[24]  D. Hafler,et al.  Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. , 1993 .

[25]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[26]  K. Yamaguchi,et al.  HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I , 1992, Japanese journal of cancer research : Gann.

[27]  A. Fauci,et al.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease , 1990, Nature.

[28]  W. Blattner,et al.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Iwasaki.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP) , 1990, Journal of the Neurological Sciences.

[30]  M. Dodon,et al.  Direct activation of resting T lymphocytes by human T-lymphotropic virus type I , 1987, Nature.

[31]  M. Nakagawa,et al.  Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. , 2004, The Journal of infectious diseases.

[32]  S. Jacobson,et al.  Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). , 2002, Blood.

[33]  H. Tsutsumi.  [Viral infection]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[34]  T. Waldmann,et al.  Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. , 2001, Journal of immunology.

[35]  T. Waldmann,et al.  Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. , 1998, Proceedings of the National Academy of Sciences of the United States of America.